Carcinoembryonic antigen peptide 1
Carcinoembryonic antigen peptide 1 (CEA peptide) is a carcinoembryonic antigen (CEA) -derived peptide. Carcinoembryonic antigen peptide 1 is a potential HLA-A*0201-restricted CTL epitope that can be used for the study of CTL-mediated epithelial-derived cancers[1].
Product Specifications
CAS Number
168635-85-6
Product Name Alternative
CEA peptide
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/carcinoembryonic-antigen-peptide-1.html
Purity
95.02
Solubility
H2O : 12.5 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(NCC(N[C@@H](C)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC1=CC=C(C=C1)O)N
Molecular Formula
C43H69N11O14
Molecular Weight
964.07
References & Citations
[1]Ras E, et al. Identification of potential HLA-A* 0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA) [J]. Human immunology, 1997, 53 (1) : 81-89.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
